private:delee
|
35691474
|
Apr 14th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 14th, 2024 03:28AM
|
Apr 14th, 2024 03:28AM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 13th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 13th, 2024 02:24AM
|
Apr 13th, 2024 02:34PM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 12th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 12th, 2024 02:36AM
|
Apr 12th, 2024 11:38AM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 11th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 11th, 2024 04:40AM
|
Apr 11th, 2024 02:18PM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 10th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 10th, 2024 02:26AM
|
Apr 10th, 2024 08:22PM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 9th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 9th, 2024 02:56AM
|
Apr 9th, 2024 01:05PM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 8th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 8th, 2024 03:27AM
|
Apr 8th, 2024 10:02PM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 7th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 7th, 2024 03:04AM
|
Apr 7th, 2024 03:04AM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 6th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 6th, 2024 02:45AM
|
Apr 6th, 2024 02:45AM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|
private:delee
|
35691474
|
Apr 5th, 2024 12:00AM
|
Delee Corp
|
778
|
16.00
|
Open
|
|
Apr 5th, 2024 05:24AM
|
Apr 5th, 2024 05:24AM
|
Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
|
Open
|
Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, and Biotechnology
|
Open
|
|
California
|
|
US
|
|
|
Delee
|
|
|